To investigate DDX11 functions in chemotherapy sensitization of cancer cells, we performed synthetic lethality drug screens in HeLa control (Ctrl) and DDX11 KO cells using 64 US Food and Drug Administration–approved drugs affecting different pathways (SI Appendix, Table S1). Here, DDX11 is linked to cancer.